Patents by Inventor Stéphane Lemaitre

Stéphane Lemaitre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Derivatives of m-Guaiacol, Their Preparation and Their Uses
    Publication number: 20210337789
    Abstract: The invention concerns derivatives of m-guaiacol, their preparation and their uses as biocides, in particular as antibacterials or disinfectants.
    Type: Application
    Filed: July 2, 2019
    Publication date: November 4, 2021
    Applicants: Universite de Caen Normandie, LABEO
    Inventors: Sylvain Rault, Christophe Rochais, Stéphane Lemaitre, Feng Xiao, Peggy Suzanne, Patrick Dallemagne, Sophie Castagnet, Albertine Leon-Seck
  • Imidazoline compounds
    Publication number: 20050143440
    Abstract: Compounds of formula (I): wherein: R1 represents an optionally substituted heteroaryl group, R2 represents an optionally substituted cycloalkyl group, R3 represents a hydrogen atom or an alkyl group, and R4 and R5 are as defined in the description, and Medicinal products containing the same are useful in the treatment of non-insulin-dependent type II diabetes, obesity, type I diabetes, hyperlipidaemia, hypercholesterolaemia and cardiovascular complications thereof.
    Type: Application
    Filed: March 1, 2005
    Publication date: June 30, 2005
    Applicant: LES LABORATORIES SERVIER
    Inventors: Sylvain Rault, Marina Kopp, Jean-Charles Lancelot, Stephane Lemaitre, Daniel-Henri Caignard, Jean-Guy Bizot-Espiard, Pierre Renard
  • Imidazoline compounds
    Patent number: 6875788
    Abstract: Compounds of formula (I): wherein: R1 represents an optionally substituted heteroaryl group, R2 represents an optionally substituted cycloalkyl group, R3 represents a hydrogen atom or an alkyl group, and R4 and R5 are as defined in the description, and Medicinal products containing the same are useful in the treatment of non-insulin-dependent type II diabetes, obesity, type I diabetes, hyperlipidaemia, hypercholesterolaemia and cardiovascular complications thereof.
    Type: Grant
    Filed: October 20, 2003
    Date of Patent: April 5, 2005
    Assignee: Les Laboratoires Servier
    Inventors: Sylvain Rault, Marina Kopp, Jean-Charles Lancelot, Stéphane Lemaitre, Daniel-Henri Caignard, Jean-Guy Bizot-Espiard, Pierre Renard
  • Imidazoline compounds
    Publication number: 20040087638
    Abstract: Compounds of formula (I): 1
    Type: Application
    Filed: October 20, 2003
    Publication date: May 6, 2004
    Inventors: Sylvain Rault, Marina Kopp, Jean-Charles Lancelot, Stephane Lemaitre, Daniel-Henri Caignard, Jean-Guy Bizot-Espiard, Pierre Renard